Randeep Guleria - Latest News Update, Information, Photos & Videos on Randeep Guleria at Lokmat Times

New Delhi, June 8 Data available till now shows clearly that efficacy of all vaccines whether Covaxin, Covishield or Sputnik V are more or less equivalent, AIIMS Director Randeep Guleria said amid rumours about differentiated abilities of Covid-19 vaccines available in India in terms of production of antibodies or higher seropositivity rate."We should not hence say take this vaccine or that vaccine, whichever vaccine is available in your area, please go ahead and get yourself vaccinated so that you and your family are safe," Guleria said while addressing various doubts of people regarding Covid-19 vaccines.Responding to commonly raised question about enough antibodies after getting vaccinated, Guleria said it is important to understand that we should not judge the efficacy of vaccines only by the amount of antibodies getting generated.The AIIMS Director said that vaccines give many types of protection such as through antibodies, cell-mediated immunity and memory cells (which generate more antibodies when we get infected).Moreover, Guleria said, the efficacy results which have come so far are based on trial studies, where the study design of each trial is somewhat different.NITI Aayog Member (Health) V.K. Paul said some people seem to be thinking of getting an antibody test done post vaccination but that is not required to be done for the simple fact that antibodies alone do not indicate the immunity of a person."This is so because of T-cells or memory cells; these undergo certain changes when we receive the vaccine, they become stronger and gain resistance power. And T-Cells are not detected by antibody tests as these are found in bone marrow."Hence, our appeal is to not fall in the tendency of doing antibody tests either before or after getting vaccinated, take the vaccine, which is available, take both doses at the right time and follow COVID Appropriate Behaviour," Paul said.He also said that the people should not be under the false notion that the vaccine is not required if he or she has had Covid-19.Currently, specifically three Covid vaccines, including Russia's Covid-19 vaccine Sputnik V the first first foreign vaccine given approval in India are being administered across the country.The other two are Serum Institute of India's Covishield and Bharat Biotech's Covaxin two "Made in India" vaccines who got the Drug Controller General of India (DCGI) approval for restricted emergency use this year that led the beginning of the world's largest vaccination drive here from January 16.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Randeep GuleriaFOLLOW

Randeep guleria, Latest News

Trials for Bharat Biotech's Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences (AIIMS) director Randeep Guleria informed. ...

The second wave of the Coronavirus had created havoc across the country. Subsequently, a large-scale vaccination campaign was launched ... ...

New Delhi, June 28 Although, Covid situation in the national capital is very much under control with daily ... ...

As India prepares for the possibility of a third wave of Covid-19 infections and deals with the new variants of Coronavirus like Delta Plus, there is a need to strengthen the public health care system of the country, said Dr Randeep Guleria, All Indi ...

New Delhi, June 25 A Supreme Court panel constituted for oxygen audit of Delhi has found numerous gaps ... ...

The second wave of corona in the country seems to be waning. However, the third wave of corona has ... ...

The third wave of Coronavirus is expected to arrive in India in the next six to eight weeks. This ... ...

New Delhi, June 8 Data available till now shows clearly that efficacy of all vaccines whether Covaxin, ... ...